We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$13.3B
Cap. Flow %
-2.57%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,612
Increased
6,434
Reduced
5,866
Closed
1,610
Avg Time Held Equity + Options
13.9 quarters
Top 10 Avg Time Held Equity + Options
17 quarters
Top 20 Avg Time Held Equity + Options
22.3 quarters
Avg Time Held Equity only
9 quarters
Top 10 Avg Time Held Equity only
1.3 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.47%
2 Technology 3.02%
3 Healthcare 2.92%
4 Consumer Discretionary 2.17%
5 Financials 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GALT icon
10301
CALL
Galectin Therapeutics
GALT
$376M
$172K ﹤0.01%
62,500
+48,900
+360% +$120K
2023 Q4
3 quarters
ESOA icon
10302
Energy Services of America
ESOA
$194M
$172K ﹤0.01%
18,085
+7,468
+70% +$63.9K
2024 Q2
1 quarter
CLNE icon
10303
PUT
Clean Energy Fuels
CLNE
$333M
$172K ﹤0.01%
55,200
-30,600
-36% -$86.7K
2013 Q2
45 quarters
VOC icon
10304
CALL
VOC Energy
VOC
$57.8M
$172K ﹤0.01%
34,800
-10,200
-23% -$50.7K
2021 Q1
14 quarters
DGII icon
10305
Digi International
DGII
$2.83B
$171K ﹤0.01%
6,229
-11,906
-66% -$314K
2022 Q4
7 quarters
HUYA
10306
CALL
Huya Inc
HUYA
$523M
$171K ﹤0.01%
33,600
-3,900
-10% -$16.8K
2018 Q2
25 quarters
RLMD icon
10307
Relmada Therapeutics
RLMD
$346M
$171K ﹤0.01%
52,846
-31,467
-37% -$102K
2020 Q4
15 quarters
EBS icon
10308
Emergent Biosolutions
EBS
$349M
$171K ﹤0.01%
20,488
-325,866
-94% -$2.96M
2013 Q2
45 quarters
MBIN icon
10309
PUT
Merchants Bancorp
MBIN
$2.28B
$171K ﹤0.01%
3,800
+2,000
+111% +$88.7K
2022 Q4
7 quarters
HEDJ icon
10310
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.74B
$171K ﹤0.01%
3,800
+3,600
+1,800% +$159K
2024 Q2
1 quarter
FRHC icon
10311
CALL
Freedom Holding
FRHC
$10.7B
$171K ﹤0.01%
1,800
-1,000
-36% -$86.9K
2022 Q4
7 quarters
GRWG icon
10312
GrowGeneration
GRWG
$90.1M
$171K ﹤0.01%
+80,078
New +$172K
2024 Q3
0 quarters
KRNT icon
10313
CALL
Kornit Digital
KRNT
$804M
$171K ﹤0.01%
6,600
-18,100
-73% -$333K
2019 Q1
22 quarters
SBS icon
10314
PUT
Sabesp
SBS
$23.6B
$170K ﹤0.01%
53,112
+46,409
+692% +$148K
2024 Q1
2 quarters
AMPH icon
10315
PUT
Amphastar Pharmaceuticals
AMPH
$1.1B
$170K ﹤0.01%
3,500
-900
-20% -$39.5K
2022 Q4
7 quarters
CXDO icon
10316
CALL
Crexendo
CXDO
$199M
$170K ﹤0.01%
36,600
+500
+1% +$2.17K
2023 Q4
3 quarters
STE icon
10317
PUT
Steris
STE
$20.6B
$170K ﹤0.01%
700
-4,300
-86% -$1.01M
2020 Q2
17 quarters
NATR icon
10318
Nature's Sunshine
NATR
$223M
$170K ﹤0.01%
12,451
-4,586
-27% -$65.8K
2024 Q2
1 quarter
OBE
10319
PUT
Obsidian Energy
OBE
$752M
$170K ﹤0.01%
30,600
-8,200
-21% -$55K
2022 Q2
9 quarters
INTT icon
10320
PUT
inTEST
INTT
$183M
$169K ﹤0.01%
23,200
+8,100
+54% +$67.2K
2022 Q3
8 quarters
NMCO icon
10321
Nuveen Municipal Credit Opportunities Fund
NMCO
$491M
$169K ﹤0.01%
14,495
-6,777
-32% -$77.1K
2024 Q2
1 quarter
NEWT icon
10322
NewtekOne
NEWT
$317M
$169K ﹤0.01%
13,569
-153,543
-92% -$1.95M
2023 Q1
6 quarters
ACNT icon
10323
Ascent Industries
ACNT
$126M
$169K ﹤0.01%
+17,418
New +$171K
2024 Q3
0 quarters
CURI icon
10324
CuriosityStream
CURI
$176M
$169K ﹤0.01%
+88,396
New +$121K
2024 Q3
0 quarters
TTGT icon
10325
PUT
TechTarget
TTGT
$299M
$169K ﹤0.01%
6,900
-100
-1% -$2.81K
2022 Q4
7 quarters

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.